NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I'm frankly saddened by the qualified people who continue to ignore the advancement of DCVax-L, not based on the Phase 3 alone, but based on what it's capable of based on the Phase 1 and 2 trials being run at UCLA and elsewhere. Even if DCVax-L by itself had no benefits, which it clearly has, it's the key to so many other therapeutics having benefits, ignoring that disturbs me more than their trying to defend the technologies they helped developed vs. DCVax-L alone.

I know that in approaching the regulators NWBO can't yet highlight, or even mention, the benefits seen by the likes of Keytruda in combination with DCVax-L, but they don't have to. The regulators aren't blind to what's happening, I cannot imagine any of them delaying approval once production issues are resolved.

Gary